The impact of time-of-day reperfusion on remote ischemic conditioning in ST-elevation myocardial infarction: a RIC-STEMI substudy.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 14 07 2022
accepted: 08 02 2023
medline: 26 5 2023
pubmed: 18 3 2023
entrez: 17 3 2023
Statut: ppublish

Résumé

Daytime variation affects the tolerance of cardiomyocytes to ischemia-reperfusion injury (IRI). This study aims to evaluate the impact of time-of-day reperfusion on clinical outcomes of remote ischemic conditioning (RIC) as an adjuvant to primary percutaneous coronary intervention(PPCI) in ST-elevation myocardial infarction(STEMI) patients. A post-hoc analysis of a prospective, single-center parallel 1:1 randomized trial (RIC-STEMI) was performed. This analysis included 448 STEMI patients previously randomized to either PPCI alone (PPCI group) (n = 217) or RIC as an adjuvant to PPCI (RIC + PPCI group) (n = 231). Moreover, the sample was divided according to the time of PPCI: night-morning (22 h-11h59min) (n = 216) or afternoon (12 h-21h59min) (n = 232) groups. The primary follow-up endpoint was a composite of cardiac death and hospitalization due to heart failure. There were no significant differences in the clinical characteristics and the follow-up outcomes between groups. The afternoon period (HR = 0.474; 95% CI 0.230-0.977; p = 0.043) and RIC (HR = 0.423; 95% CI 0.195-0.917; p = 0.029) were independent predictors of the primary follow-up endpoint. An univariate analysis showed a lower frequency of primary follow-up endpoint, just in the afternoon period (10.3%vs0.9%; p = 0.002), in the RIC + PPCI group. A multivariate analysis revealed that RIC was an independent predictor of the primary follow-up endpoint in the afternoon group (HR = 0.098; 95% CI 0.012-0.785; p = 0.029), but not in the night-morning group. In addition, the afternoon period was not an independent predictor of the primary follow-up endpoint when the multivariate analysis was performed in the PPCI group. In conclusion, this study showed an important cardioprotective effect of RIC, namely in the afternoon period, suggesting that the afternoon period enhances the cardioprotection induced by RIC.

Identifiants

pubmed: 36930231
doi: 10.1007/s00380-023-02247-8
pii: 10.1007/s00380-023-02247-8
pmc: PMC10209246
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

909-918

Subventions

Organisme : FP7 Ideas: European Research Council
ID : Projects PEst-C/SAU/UI0051/2011
Organisme : FP7 Ideas: European Research Council
ID : EXCL/BIM-MEC/0055/2012

Informations de copyright

© 2023. The Author(s).

Références

Basic Res Cardiol. 2016 Jul;111(4):41
pubmed: 27164905
JAMA. 2011 Apr 27;305(16):1677-84
pubmed: 21521849
Basic Res Cardiol. 2018 Mar 7;113(3):14
pubmed: 29516192
Chronobiologia. 1982 Apr-Jun;9(2):195-201
pubmed: 7117042
Eur Heart J. 2015 Nov 21;36(44):3049-57
pubmed: 26385956
Circ Res. 2012 Jan 6;110(1):105-10
pubmed: 22095727
PLoS One. 2011;6(9):e24549
pubmed: 21931750
Cond Med. 2018 Aug;1(5):13-22
pubmed: 30338313
Am Heart J. 2005 Dec;150(6):1185-9
pubmed: 16338256
Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1082
pubmed: 29198432
N Engl J Med. 1987 Jun 11;316(24):1514-8
pubmed: 3587281
Lancet. 2019 Oct 19;394(10207):1415-1424
pubmed: 31500849
Basic Res Cardiol. 2020 Apr 25;115(3):35
pubmed: 32335728
N Engl J Med. 2007 Sep 13;357(11):1121-35
pubmed: 17855673
Am Heart J. 2012 Feb;163(2):208-13
pubmed: 22305838
Lancet. 2018 Jan 6;391(10115):59-69
pubmed: 29107324
Clin Res Cardiol. 2018 Apr;107(4):338-346
pubmed: 29222592
Pharmacol Rev. 2014 Oct;66(4):1142-74
pubmed: 25261534
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):178-188
pubmed: 25240548
Circulation. 2004 Mar 16;109(10):1223-5
pubmed: 15007008
Eur Heart J. 2017 Mar 14;38(11):774-784
pubmed: 27354052
Eur Heart J. 2014 Jan;35(3):168-75
pubmed: 24031025
J Clin Invest. 2013 Jan;123(1):92-100
pubmed: 23281415
Eur Heart J. 2015 Oct 21;36(40):2696-705
pubmed: 26306399
Basic Res Cardiol. 2021 Oct 14;116(1):59
pubmed: 34648075
Heart. 2011 Jun;97(12):970-6
pubmed: 21525526
Int J Cardiol. 2017 Mar 1;230:149-154
pubmed: 28038815

Auteurs

Carla Marques Pires (CM)

Department of Cardiology, Braga Hospital, Braga, Portugal.

Diana Lamas (D)

Minho University, Braga, Portugal.

António Gaspar (A)

Department of Cardiology, Braga Hospital, Braga, Portugal.
Department of Surgery and Physiology, UnIC@RISE, Faculty of Medicine of the University of Porto, Porto, Portugal.

André P Lourenço (AP)

Department of Surgery and Physiology, UnIC@RISE, Faculty of Medicine of the University of Porto, Porto, Portugal.

Nuno Antunes (N)

Department of Cardiology, Braga Hospital, Braga, Portugal.

Jorge Marques (J)

Department of Cardiology, Braga Hospital, Braga, Portugal.

Adelino F Leite-Moreira (AF)

Department of Surgery and Physiology, UnIC@RISE, Faculty of Medicine of the University of Porto, Porto, Portugal. amoreira@med.up.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH